It is intended for qualified research environments studying copper-binding peptide complexes, cellular signalling activity and related biochemical pathways
EVS is capable of being chemically modified to be targeted

Pharmaceutically acceptable carriers and diluents are well known in the art (see, e.g., Remington, The Science and Practice of Pharmacy (21 st Edition, Lippincott Williams and Wilkins, Philadelphia, Pa.) and The National Formulary (American Pharmaceutical Association, Washington, D.C.)) and include sugars (e.g., lactose, sucrose, mannitol, and sorbitol), starches, cellulose preparations, calcium phosphates (e.g., dicalcium phosphate, tricalcium phosphate and calcium hydrogen phosphate), sodium citrate, water, aqueous solutions (e.g., saline, sodium chloride injection, Ringer's injection, dextrose injection, dextrose and sodium chloride injection, lactated Ringer's injection), alcohols (e.g., ethyl alcohol, propyl alcohol, and benzyl alcohol), polyols (e.g., glycerol, propylene glycol, and polyethylene glyco Each pharmaceutically acceptable carrier or diluent used in a composition of the invention must be acceptable in the sense of being compatible with the other ingredients of the formulation and not injurious to the subject

As a key player in immune responses and disease progression, it is a promising therapeutic target
The conserved Box 1 motif of cytokine receptors is required for association with JAK kinases